SIK2 and pemphigus foliaceus: Our results showed that SIK2 inhibitors reduced fibrosis markers in these lung slices, indicating that SIK2 inhibition can effectively mitigate PF in a model that closely resembles the in vivo human condition (Figure 5A,B).